Search

Zhu, Kejia, Warren G Hill, Fangyong Li, Benkang Shi, and Toby C Chai. 2020. “Early Increased Urinary IL-2 and IL-10 Levels Were Associated With Development of Chronic UTI in a Murine Model.”. Urology 141: 188.e1-188.e6.

Zeidel, Mark L, Carolyn Kirk, and Ben Linville-Engler. 2020. “Opening Up New Supply Chains.”. The New England Journal of Medicine 382 (21): e73.

Silveira, Tammyris Helena Rebecchi, Fábio Henrique Silva, Warren G Hill, Edson Antunes, and Mariana G de Oliveira. 2024. “Targeting NADPH Oxidase As an Approach for Diabetic Bladder Dysfunction.”. Antioxidants (Basel, Switzerland) 13 (10).

Chen, Huan, Ali Wu, Mark L Zeidel, and Weiqun Yu. 2022. “Smooth Muscle Insulin Receptor Deletion Causes Voiding Dysfunction: A Mechanism for Diabetic Bladder Dysfunction.”. Diabetes 71 (10): 2197-2208.

de Oliveira, Mariana G, Fabíola Z Monica, Gabriela R Passos, Jamaira A Victorio, Ana Paula Davel, Anna Lethicia Lima Oliveira, Carlos A Parada, Carlos A L D’Ancona, Warren G Hill, and Edson Antunes. 2022. “Selective Pharmacological Inhibition of NOX2 by GSK2795039 Improves Bladder Dysfunction in Cyclophosphamide-Induced Cystitis in Mice.”. Antioxidants (Basel, Switzerland) 12 (1).

Qiu, Chenxi, Onder Albayram, Asami Kondo, Bin Wang, Nami Kim, Ken Arai, Cheng-Yu Tsai, et al. 2021. “Cis P-Tau Underlies Vascular Contribution to Cognitive Impairment and Dementia and Can Be Effectively Targeted by Immunotherapy in Mice.”. Science Translational Medicine 13 (596).

MacIver, Bryce, Ali Wu, Warren G Hill, and Weiqun Yu. 2024. “DREADD Agonist Compound 21 Causes Acute Diuresis in Wild-Type Mice.”. Frontiers in Pharmacology 15: 1471059.

Yu, Weiqun. 2022. “Reviving Cav1.2 As an Attractive Drug Target to Treat Bladder Dysfunction.”. FASEB Journal 36 (1): e22118.

Duan, Bingbing, Chenxi Qiu, Steve W Lockless, Sing-Hoi Sze, and Craig D Kaplan. 2024. “Higher-Order Epistasis Within Pol II Trigger Loop Haplotypes.”. Genetics 228 (4).

Jash, Sukanta, Sayani Banerjee, Shibin Cheng, Bin Wang, Chenxi Qiu, Asami Kondo, Jan Ernerudh, Xiao Zhen Zhou, Kun Ping Lu, and Surendra Sharma. 2023. “Cis P-Tau Is a Central Circulating and Placental Etiologic Driver and Therapeutic Target of Preeclampsia.”. Nature Communications 14 (1): 5414.